Drug application
ENFLURANE (ENFLURANE)
Drugs@FDA ANDA 074396 · PIRAMAL CRITICAL
Key facts
| Drug name | ENFLURANE |
|---|---|
| Active ingredients | ENFLURANE |
| Application type | ANDA |
| Application number | 074396 |
| Company | PIRAMAL CRITICAL |
| Dosage forms | LIQUID, INHALATION |
| Strength | 99.9% |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jul 29, 1994 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.